6-hydroxy-buspirone regulatory update

BMY received U.S. Patent No. 6,150,365 covering the use of 6-hydroxy-buspirone, a metabolite of BMY's marketed BuSpar buspirone anxiolytic drug, to treat anxiety. BMY said the metabolite is largely r...